These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

493 related items for PubMed ID: 1321426

  • 21. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins.
    Zhang QJ, Gavioli R, Klein G, Masucci MG.
    Proc Natl Acad Sci U S A; 1993 Mar 15; 90(6):2217-21. PubMed ID: 8384718
    [Abstract] [Full Text] [Related]

  • 22. Generation of HLA-B55 restricted T lymphocyte mediated cytotoxicity against autologous LCL.
    Avila-Cariño J, Végh Z, Klein E.
    Mol Immunol; 1994 Jan 15; 31(1):59-63. PubMed ID: 8302299
    [Abstract] [Full Text] [Related]

  • 23. Distinction between Epstein-Barr virus type A (EBNA 2A) and type B (EBNA 2B) isolates extends to the EBNA 3 family of nuclear proteins.
    Rowe M, Young LS, Cadwallader K, Petti L, Kieff E, Rickinson AB.
    J Virol; 1989 Mar 15; 63(3):1031-9. PubMed ID: 2536817
    [Abstract] [Full Text] [Related]

  • 24. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population.
    de Campos-Lima PO, Gavioli R, Zhang QJ, Wallace LE, Dolcetti R, Rowe M, Rickinson AB, Masucci MG.
    Science; 1993 Apr 02; 260(5104):98-100. PubMed ID: 7682013
    [Abstract] [Full Text] [Related]

  • 25. Class I major histocompatibility complex-restricted cytotoxic T lymphocytes specific for Epstein-Barr virus (EBV)-transformed B lymphoblastoid cell lines against which they were raised.
    Hill AB, Lee SP, Haurum JS, Murray N, Yao QY, Rowe M, Signoret N, Rickinson AB, McMichael AJ.
    J Exp Med; 1995 Jun 01; 181(6):2221-8. PubMed ID: 7539044
    [Abstract] [Full Text] [Related]

  • 26. Natural variants of the immunodominant HLA A11-restricted CTL epitope of the EBV nuclear antigen-4 are nonimmunogenic due to intracellular dissociation from MHC class I:peptide complexes.
    Levitsky V, Zhang QJ, Levitskaya J, Kurilla MG, Masucci MG.
    J Immunol; 1997 Dec 01; 159(11):5383-90. PubMed ID: 9548478
    [Abstract] [Full Text] [Related]

  • 27. Lymphoblastoid cell lines and Burkitt-lymphoma-derived cell lines differ in the expression of a second Epstein-Barr virus encoded nuclear antigen.
    Ernberg I, Kallin B, Dillner J, Falk K, Ehlin-Henriksson B, Hammarskjöld ML, Klein G.
    Int J Cancer; 1986 Nov 15; 38(5):729-37. PubMed ID: 3021635
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F, Gregory C, Sample C, Rowe M, Liebowitz D, Murray R, Rickinson A, Kieff E.
    J Virol; 1990 May 15; 64(5):2309-18. PubMed ID: 2157887
    [Abstract] [Full Text] [Related]

  • 29. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
    Masucci MG, Contreras-Salazar B, Ragnar E, Falk K, Minarovits J, Ernberg I, Klein G.
    J Virol; 1989 Jul 15; 63(7):3135-41. PubMed ID: 2470924
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
    Dolcetti R, Frisan T, Sjöberg J, De Campos-Lima PO, Pisa P, De Re V, Gloghini A, Rizzo S, Masucci MG, Boiocchi M.
    Cancer Res; 1995 Aug 15; 55(16):3675-81. PubMed ID: 7627978
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differentiation-dependent sensitivity of human B-cell-derived lines to major histocompatibility complex-restricted T-cell cytotoxicity.
    Torsteinsdottir S, Masucci MG, Ehlin-Henriksson B, Brautbar C, Ben Bassat H, Klein G, Klein E.
    Proc Natl Acad Sci U S A; 1986 Aug 15; 83(15):5620-4. PubMed ID: 3016710
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.